The University of Chicago Header Logo

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease. N Engl J Med. 2016 11 17; 375(20):1946-1960.

View in: PubMed